Adams Diversified Equity Fund’s Gilead Sciences GILD Stock Holding History

Adams Diversified Equity Fund’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-177,100	Closed	-$24.7M	–	108
2026 Q1	$24.7M	Hold	177,100	–	–	0.87%	32
2025 Q4	$21.7M	Buy	+177,100	New	+$21.5M	0.72%	42
2017 Q1	–	Sell	-55,500	Closed	-$3.97M	–	211
2016 Q4	$3.97M	Sell	55,500 -165,800	-75%	-$12.3M	0.25%	78
2016 Q3	$18.5M	Hold	221,300	–	–	1.24%	32
2016 Q2	$18.5M	Hold	221,300	–	–	1.24%	32
2016 Q1	$20.3M	Sell	221,300 -14,600	-6%	-$1.32M	1.42%	28
2015 Q4	$23.9M	Sell	235,900 -40,000	-14%	-$4.16M	1.64%	19
2015 Q3	$27.1M	Sell	275,900 -60,700	-18%	-$6.74M	1.95%	16
2015 Q2	$39.4M	Sell	336,600 -39,300	-10%	-$4.29M	2.6%	4
2015 Q1	$36.9M	Hold	375,900	–	–	2.43%	6
2014 Q4	$35.4M	Hold	375,900	–	–	2.34%	6
2014 Q3	$40M	Sell	375,900 -38,100	-9%	-$3.73M	2.64%	4
2014 Q2	$34.3M	Hold	414,000	–	–	2.29%	5
2014 Q1	$29.3M	Hold	414,000	–	–	2.07%	8
2013 Q4	$31.1M	Hold	414,000	–	–	2.2%	5
2013 Q3	$26M	Hold	414,000	–	–	1.98%	11
2013 Q2	$21.2M	Buy	+414,000	New	+$21.6M	1.68%	19

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adams Diversified Equity Fund's GILD Position: Q2 2026 in Review

Adams Diversified Equity Fund sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 177,100 shares — an estimated $24.7M sold.

Adams Diversified Equity Fund first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $40M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Adams Diversified Equity Fund reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Adams Diversified Equity Fund sold 177,100 Gilead Sciences shares in Q2 2026, an estimated $24.7M.
Adams Diversified Equity Fund first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
Adams Diversified Equity Fund's Gilead Sciences position peaked at $40M in Q3 2014.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2026, filed 22 Jul 2026.